Tuesday, February 27, 2024

Pa. Health facility Consolidation Continues With Penn Drugs-Doylestown Deal


Simply weeks after Philadelphia-based Jefferson Well being and Allentown, Pa.-based Lehigh Valley Well being Community (LVHN) introduced plans to merge, the College of Pennsylvania Well being Machine (UPHS) and Doylestown Well being leaders introduced plans for the Greenbacks County well being device to turn into a part of Penn Drugs.

Doylestown Well being is a not-for-profit, clinically built-in community of care, with its flagship being 247-bed Doylestown Health facility, which might turn into the 7th Penn Drugs health facility. Along with its 3 Philadelphia hospitals — the Health facility of the College of Pennsylvania, Penn Presbyterian Clinical Middle, and Pennsylvania Health facility — Chester County Health facility, Lancaster Normal Well being, and Princeton Well being are a part of UPHS, having joined in 2013, 2015, and 2018, respectively.

“Penn Drugs objectives to supply choices for sufferers in every single place in our area, regardless of the place they are living. From receiving number one care and having a toddler to present process orthopedic surgical treatment or receiving complicated remedy for most cancers or middle illness, we wish it to be simple for sufferers to select Penn Drugs throughout their lifespan,” stated UPHS CEO Kevin Mahoney, in a remark. “We’re excited to discover this chance with Doylestown Well being, which has a powerful, ancient dedication to sufferers within the Northern area of the spaces we serve.”

The organizations stated the brand new partnership will construct upon present scientific integration between UPHS and Doylestown Well being. Penn Radiation Oncology at Doylestown, as an example, opened in 2011 and delivers handle greater than 400 sufferers each and every yr. For greater than a decade, Doylestown Health facility has been a part of the Penn Most cancers Community, a bunch of hospitals and doctor practices during the higher Philadelphia area taking part with Penn Drugs’s Abramson Most cancers Middle to supply expanded get admission to to therapies and scientific trials. 

Penn Drugs famous that the announcement of the proposed partnership is a initial step in a procedure that may ultimate a number of months. As soon as due diligence is done and definitive agreements were signed, the plans shall be reviewed by means of all vital federal and state regulators. 

The similar holds true for the Jefferson-Lehigh Valley deal. That blended device would perform 30 hospitals and greater than 700 websites of care, supported by means of greater than 62,000 hired college, clinicians and workforce in Jap Pennsylvania and Southern New Jersey.


Please enter your comment!
Please enter your name here

Related Stories